PATENT CLAIM ANALYSIS

Application Number: 16069326
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["546", "156000"]

Abstract:
Compounds of the formula I in which X 1 , X 2 , X 3 , X 4 , R 1 , R 2 , R 3 , Q and Y have the meanings indicated in Claim  1,  are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.

Claim (Index 5):
Compounds according to  claim 1 , in which\n Het\u2032 denotes pyrrolidinyl, and pharmaceutically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.71875
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14909365', '15566933', '13546039', '14772865', '14908217']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7855153520900657
- 35 USC 102 Novelty (BERT): 0.5318239394680335
- Combined Prediction Score: 0.7601462108278625
- Mean Citation Score: 331.6542
- Max Citation Score: 348.71225
- Similarity Product: 266.9816108838021

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test